MOLECULAR REGULATION OF LRAT AND CYP26 IN LIVER
肝脏中 LRAT 和 CYP26 的分子调控
基本信息
- 批准号:6650248
- 负责人:
- 金额:$ 25.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-01 至 2006-08-31
- 项目状态:已结题
- 来源:
- 关键词:acyltransferase complementary DNA cytochrome P450 diet enzyme activity enzyme induction /repression genetic promoter element hepatocellular carcinoma human tissue immunocytochemistry in situ hybridization laboratory rat liver cells liver cirrhosis liver metabolism molecular cloning nucleic acid sequence nutrition related tag retinoate vitamin metabolism
项目摘要
Retinoic acid and related retinoids are potent hormone-like ligand for two families of ligand-activated nuclear receptors, RAR and RXR. Retinoic acid is synthesized from vitamin A precursors in a variety of cells where it potentially acts in situ to induce gene expression, control growth, and promote normal cellular differentness. These actions make retinoids a great interest in situ chemoprevention of cancer. Despite many advances in retinoid receptor biology, our understanding of the factors that regulate endogenous retinoid concentrations has lagged behind. Understanding the production and catabolism of retinoids is critical to understanding their receptor-mediated actions. The central hypothesis to be tested is that two liver microsomal enzymes - lecithin: retinol acyltransferase, LRAT, and cytochrome P450RA1, or CYP26- serve as key regulators of Retinoic acid biosynthesis and catabolism, respectively. Recently we have cloned LRAT cDNA from rat and mouse liver. Preliminary studies are presented in which LRAT and CYP26 gene expression was strongly regulated in liver, both actually by exogenous retinoids and chronically by dietary vitamin A. To critically test our hypothesis we will conduct 4 specific aims. In aim 1 we will examine retinoid- and diet- induced differences in LRAT and CYP26 gene expression and retinoid metabolism in intact rats. In aim 2 we will investigate which liver cell types express LRAT and CYP26 and further test our model of retinoid metabolism in hepatocytes and stellate cells. In aim 3, we will sequence the homologous cDNA for human liver LRAT and conduct molecular studies of LRAT and CYP26 expression in normal and diseased liver specimens available from the Liver Tissue Procurement and Distribution System (LTPADS). In aim 4, we will study the 5' regulatory regions of the LRAT and CYP26 genes to determine the molecular basis for their responsiveness to Retinoic acid in liver. By investigating both LRAT and CYP26 simultaneously we expect to obtain novel insights into the molecular and cell-type specific regulation of Retinoic acid biosynthesis and degradation. This information could shed new light on the endogenous factors that control the availability of Retinoic acid in tissues and plasma which, in turn, are likely to affect Retinoic acid's anticarcinogenic potential.
视黄酸和相关的类视黄酸是两个配体激活的核受体家族RAR和RXR的有效的类视黄酸配体。视黄酸是由维生素A前体在多种细胞中合成的,在这些细胞中,视黄酸可能原位作用以诱导基因表达、控制生长并促进正常细胞差异。这些作用使得类维生素A在癌症的原位化学预防中引起了极大的兴趣。尽管在类维生素A受体生物学方面取得了许多进展,但我们对调节内源性类维生素A浓度的因素的理解仍然落后。了解类维生素A的产生和释放对于了解其受体介导的作用至关重要。待检验的中心假设是两种肝微粒体酶-卵磷脂:视黄醇酰基转移酶,LRAT和细胞色素P450 RA 1或CYP 26-分别作为视黄酸生物合成和催化剂的关键调节剂。最近,我们已经从大鼠和小鼠肝脏中克隆了LRAT cDNA。初步研究表明,LRAT和CYP 26基因表达在肝脏中受到强烈调控,实际上都是由外源性类维生素A和膳食维生素A长期调控。为了严格检验我们的假设,我们将进行4个具体目标。在目标1中,我们将研究类维生素A和饮食诱导的LRAT和CYP 26基因表达和类维生素A代谢在完整大鼠中的差异。在目标2中,我们将研究哪些肝细胞类型表达LRAT和CYP 26,并进一步测试我们的肝细胞和星状细胞中类维生素A代谢模型。在目标3中,我们将对人类肝脏LRAT的同源cDNA进行测序,并对来自肝脏组织采购和分配系统(LTPADS)的正常和患病肝脏标本中的LRAT和CYP 26表达进行分子研究。在目标4中,我们将研究LRAT和CYP 26基因的5'调控区,以确定其对肝脏中维甲酸反应性的分子基础。通过同时研究LRAT和CYP 26,我们希望获得有关维甲酸生物合成和降解的分子和细胞类型特异性调节的新见解。这一信息可以揭示控制组织和血浆中维甲酸可用性的内源性因素,这些因素反过来可能影响维甲酸的抗癌潜力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
A. CATHARINE ROSS其他文献
A. CATHARINE ROSS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('A. CATHARINE ROSS', 18)}}的其他基金
Vitamin A Supplementation and Retinol Metabolism in the Neonatal Period
新生儿期维生素A的补充和视黄醇的代谢
- 批准号:
9105886 - 财政年份:2010
- 资助金额:
$ 25.04万 - 项目类别:
Vitamin A Supplementation and Retinol Metabolism in the Neonatal Period
新生儿期维生素 A 补充和视黄醇代谢
- 批准号:
9414608 - 财政年份:2010
- 资助金额:
$ 25.04万 - 项目类别:
Retinoid Nutritional Status and Immune Function
类维生素A营养状况和免疫功能
- 批准号:
8013381 - 财政年份:2010
- 资助金额:
$ 25.04万 - 项目类别:
Vitamin A Supplementation and Retinol Metabolism in the Neonatal Period
新生儿期维生素 A 补充和视黄醇代谢
- 批准号:
8132556 - 财政年份:2010
- 资助金额:
$ 25.04万 - 项目类别:
Vitamin A Supplementation and Retinol Metabolism in the Neonatal Period
新生儿期维生素A的补充和视黄醇的代谢
- 批准号:
8488455 - 财政年份:2010
- 资助金额:
$ 25.04万 - 项目类别:
Vitamin A Supplementation and Retinol Metabolism in the Neonatal Period
新生儿期维生素A的补充和视黄醇的代谢
- 批准号:
8607636 - 财政年份:2010
- 资助金额:
$ 25.04万 - 项目类别:
Vitamin A Supplementation and Retinol Metabolism in the Neonatal Period
新生儿期维生素 A 补充和视黄醇代谢
- 批准号:
8008598 - 财政年份:2010
- 资助金额:
$ 25.04万 - 项目类别:
Vitamin A Supplementation and Retinol Metabolism in the Neonatal Period
新生儿期维生素A的补充和视黄醇的代谢
- 批准号:
9264566 - 财政年份:2010
- 资助金额:
$ 25.04万 - 项目类别:
Vitamin A Supplementation and Retinol Metabolism in the Neonatal Period
新生儿期维生素 A 补充和视黄醇代谢
- 批准号:
8311050 - 财政年份:2010
- 资助金额:
$ 25.04万 - 项目类别:
Molecular Regulation of LRAT and CYP26 in Lung and Liver
肺和肝中 LRAT 和 CYP26 的分子调控
- 批准号:
7614282 - 财政年份:2008
- 资助金额:
$ 25.04万 - 项目类别:
相似海外基金
Development of a highly integrated circuit using DNA and a demonstration test of the parallel computation using a complementary DNA as an operator
使用DNA的高度集成电路的开发以及使用互补DNA作为算子的并行计算的演示测试
- 批准号:
17K06395 - 财政年份:2017
- 资助金额:
$ 25.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Quantitative analysis in neurotrophic factor genes of spinal cord with complementary DNA microarray
互补DNA微阵列定量分析脊髓神经营养因子基因
- 批准号:
18390411 - 财政年份:2006
- 资助金额:
$ 25.04万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis of gene expression following maxillofacial inflammation in rat using complementary DNA microarray
使用互补 DNA 微阵列分析大鼠颌面部炎症后的基因表达
- 批准号:
15390628 - 财政年份:2003
- 资助金额:
$ 25.04万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Complementary DNA cloning and characterization of rat spergen-3,a spermatogenic cell-specific gene-3,expressed in mammalian spermatogenic cells
大鼠 spergen-3(生精细胞特异性基因 3,在哺乳动物生精细胞中表达)的互补 DNA 克隆和表征
- 批准号:
15570179 - 财政年份:2003
- 资助金额:
$ 25.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Microbial Genome Sequencing: Gene Discovery and Mapping Tools for Ichthyophthirius: A Complementary DNA Resource
微生物基因组测序:鱼霉属基因发现和作图工具:补充 DNA 资源
- 批准号:
0333246 - 财政年份:2003
- 资助金额:
$ 25.04万 - 项目类别:
Continuing Grant
GENE EXPRESSION ANALYSIS OF THE SPINAL CORD UNDER CHRONIC MECHANICAL COMPRESSION USING IN-HOUSE COMPLEMENTARY DNA MICROARRAY
使用内部互补 DNA 微阵列对慢性机械压迫下的脊髓进行基因表达分析
- 批准号:
15591563 - 财政年份:2003
- 资助金额:
$ 25.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Effects of antisense vascular endothelial growth factor complementary DNA on the growth of human glioma cells.
反义血管内皮生长因子互补DNA对人胶质瘤细胞生长的影响。
- 批准号:
07671538 - 财政年份:1995
- 资助金额:
$ 25.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)